Alesis today announced a joint venture partnership with Lake Norman Pulmonary & Sleep in Mooresville, North Carolina — making it the first sleep medicine practice in the Piedmont region to offer Alesis OSA1, a non-surgical treatment for patients with obstructive sleep apnea (OSA) who cannot tolerate CPAP therapy.
Alesis OSA1 is an FDA-cleared, prescription-only medical device that uses a patented, high-powered non-laser light — photonic lipolysis — to permanently reduce the localized fat deposits in the neck, tongue, throat and airway that are the leading anatomical cause of airway obstruction in most OSA patients. The procedure requires no surgery, no needles, no anesthesia and no recovery time. Patients receive six 12-minute in-office treatments over three weeks.
The device is manufactured in the United States by Photonica USA, in Cocoa Beach, Florida, and holds three FDA clearances, along with 11 utility patents granted in 31 countries. The underlying technology has been FDA-cleared for more than a decade.
